Abstract:Bioactive macromolecular drugs known as Growth Factors (GFs), approved by the Food and Drug Administration (FDA), have found successful application in clinical practice. They hold significant promise for addressing peripheral nerve injuries (PNIs). Peripheral nerve guidance conduits (NGCs) loaded with GFs, in the context of tissue engineering, can ensure sustained and efficient release of these bioactive compounds. This, in turn, maintains a stable, long-term, and effective GF concentration essential for treating damaged peripheral nerves. Peripheral nerve regeneration is a complex process that entails the secretion of various GFs. Following PNI, GFs play a pivotal role in promoting nerve cell growth and survival, axon and myelin sheath regeneration, cell differentiation, and angiogenesis. They also regulate the regenerative microenvironment, stimulate plasticity changes post-nerve injury, and, consequently, expedite nerve structure and function repair. Both exogenous and endogenous GFs, including NGF, BDNF, NT-3, GDNF, IGF-1, bFGF, and VEGF, have been successfully loaded onto NGCs using techniques like physical adsorption, blend doping, chemical covalent binding, and engineered transfection. These approaches have effectively promoted the repair of peripheral nerves. Numerous studies have demonstrated similar tissue functional therapeutic outcomes compared to autologous nerve transplantation. This evidence underscores the substantial clinical application potential of GFs in the domain of peripheral nerve repair. In this article, we provide an overview of GFs in the context of peripheral nerve regeneration and drug delivery systems utilizing NGCs. Looking ahead, commercial materials for peripheral nerve repair hold the potential to facilitate the effective regeneration of damaged peripheral nerves and maintain the functionality of distant target organs through the sustained release of GFs.

Challenges and Progress of Neurodrug: Bioactivities, Production and Delivery Strategies of Nerve Growth Factor Protein

Nerve Growth Factor Biodelivery: A Limiting Step in Moving Toward Extensive Clinical Application?

Efficient Delivery of Nerve Growth Factors to the Central Nervous System for Neural Regeneration.

The History of Nerve Growth Factor: From Molecule to Drug

Growth factors: Bioactive macromolecular drugs for peripheral nerve injury treatment – Molecular mechanisms and delivery platforms

Advanced Noninvasive Strategies for the Brain Delivery of Therapeutic Proteins and Peptides

Delivery of Neuroregenerative Proteins to the Brain for Treatments of Neurodegenerative Brain Diseases

The Therapeutic Potentials of Neurotrophic Factors for Diseases of the Nervous System

Development of neurotrophic molecules for treatment of neurodegeneration

Nanoparticles for neurotrophic factor delivery in nerve guidance conduits for peripheral nerve repair.

Multifaceted Roles of Nerve Growth Factor: A Comprehensive Review with a Special Insight into Pediatric Perspectives

Intranasal Administration: a Potential Solution for Cross-Bbb Delivering Neurotrophic Factors.

Theoretical research and clinical application of nerve tissue-engineering release-controlled system

Increased encapsulated cell biodelivery of nerve growth factor in the brain by transposon-mediated gene transfer

Nanoparticle Mediated Controlled Delivery of Dual Growth Factors

Systemic Delivery to Central Nervous System by Engineered Plga Nanoparticles

Gene delivery strategies for therapeutic proteins production in plants: Emerging opportunities and challenges

Nanoparticles Improve the Passage of Nerve Growth Factor Through Blood-Brain Barrier by Stimulating A β Clearance

Nanogels as Novel Nanocarrier Systems for Efficient Delivery of CNS Therapeutics

Gelatin Nanostructured Lipid Carriers Incorporating Nerve Growth Factor Inhibit Endoplasmic Reticulum Stress-Induced Apoptosis and Improve Recovery in Spinal Cord Injury

Recent Advances in Nanotherapeutics for Neurological Disorders